Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Cadila Healthcare arm gets USFDA nod to market Ranitidine injection

      Cadila Healthcare arm gets USFDA nod to market Ranitidine injection

      Medical Dialogues Bureau12 Dec 2018 10:00 AM IST
      NEW DELHI: Drug firm Cadila Healthcare on Tuesday said its subsidiary has received approval from the US health regulator to market Ranitidine...
      Strides JV gets USFDA nod for Albendazole tablets

      Strides JV gets USFDA nod for Albendazole tablets

      Medical Dialogues Bureau12 Dec 2018 9:45 AM IST
      New Delhi: Drug firm Strides Pharma Science recently said its joint venture (JV) firm has received approval from the US health regulator for...
      Madras High Court to soon pronounce verdict in case of ban on online sale of medicines

      Madras High Court to soon pronounce verdict in case of ban on online sale of medicines

      Medical Dialogues Bureau11 Dec 2018 9:45 AM IST
      Chennai: The result in case of the ban on the online sale of medicines without a valid licence will soon be pronounced by the Madras High Court, as of...
      Lupin gets EIR from USFDA for Pithampur facility unit

      Lupin gets EIR from USFDA for Pithampur facility unit

      Medical Dialogues Bureau11 Dec 2018 9:40 AM IST
      Mumbai: Through a recent press release Drug firm Lupin recently announced the receipt of the Establishment Inspection Report (EIR) for its Pithampur...
      Tivity Health to buy Nutrisystem for Rs 140 crores

      Tivity Health to buy Nutrisystem for Rs 140 crores

      Medical Dialogues Bureau11 Dec 2018 9:15 AM IST
      New Delhi: Tivity Health Inc said recently it would buy diet plan developer Nutrisystem Inc for $1.4 billion(Rs 140 crores) in cash and stock, as it...
      Shanghai Junshi Biosciences seeks up to $414 million in Hong Kong IPO

      Shanghai Junshi Biosciences seeks up to $414 million in Hong Kong IPO

      Medical Dialogues Bureau11 Dec 2018 9:00 AM IST
      HONG KONG: Chinese biotech company Shanghai Junshi Biosciences is seeking up to $414 million in a Hong Kong initial public offering (IPO), making it...
      Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

      Alembic Pharma gets USFDA nod for Olopatadine Hydrochloride ophthalmic solution

      Medical Dialogues Bureau10 Dec 2018 9:15 AM IST
      New Delhi: Drug firm Alembic Pharma on Monday said it has received approval from the US health regulator for Olopatadine Hydrochloride ophthalmic...
      Fresenius plunges as health firm warns investment to hit profit

      Fresenius plunges as health firm warns investment to hit profit

      Medical Dialogues Bureau10 Dec 2018 9:00 AM IST
      Among its projects, the German company is developing copies of off-patent biotech drugs known as biosimilars and is also increasing output capacity in...
      Sterling Biotech bank fraud case,ED attaches property worth 4700 crores

      Sterling Biotech bank fraud case,ED attaches property worth 4700 crores

      Medical Dialogues Bureau8 Dec 2018 10:20 AM IST
      New Delhi: The Enforcement Directorate (ED) on Friday, after a seven-month-long probe, attached several movable and immovable properties worth more...
      Bayer reduces combined sales estimate for its experimental drugs

      Bayer reduces combined sales estimate for its experimental drugs

      Medical Dialogues Bureau8 Dec 2018 9:20 AM IST
      FRANKFURT: Germany's Bayer, which acquired seed company, Monsanto, this year, reduced its combined sales estimate for its most promising experimental...
      AstraZeneca enters distribution agreement with Abbott for diabetes drug

      AstraZeneca enters distribution agreement with Abbott for diabetes drug

      Medical Dialogues Bureau8 Dec 2018 9:00 AM IST
      New Delhi: Drug firm AstraZenecaPharma India Friday said it has entered into a distribution agreement with Abbott Healthcare for distribution of...
      Compensation formula unacceptable, done without due consultations, say patients of faulty JJ implant

      Compensation formula unacceptable, done without due consultations, say patients of faulty JJ implant

      Medical Dialogues Bureau7 Dec 2018 4:09 PM IST
      New Delhi: Days after the Centre approved a formula for determination of compensation, a group of patients affected by Johnson and Johnson's faulty...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok